Michael T Borchers Selected Research

Michael T Borchers Research Topics

Disease

18	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 05/2002
7	Inflammation (Inflammations) 01/2021 - 05/2002
5	Infections 01/2020 - 05/2006
4	Lung Diseases (Lung Disease) 07/2020 - 03/2009
3	Emphysema 09/2019 - 12/2008
3	Pneumonia (Pneumonitis) 04/2010 - 12/2007
3	Metaplasia 12/2009 - 09/2008
3	Acute Lung Injury 08/2009 - 12/2005
2	Persistent Infection 01/2021 - 12/2009
2	Lung Injury 07/2020 - 08/2009
2	Asthma (Bronchial Asthma) 01/2020 - 04/2002
2	Neoplasms (Cancer) 10/2017 - 12/2008
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 10/2017 - 10/2016
2	Fibrosis (Cirrhosis) 04/2010 - 12/2009
2	Respiratory Hypersensitivity 07/2003 - 01/2003
1	Chronic Bronchitis 01/2021
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2020
1	Respiratory Syncytial Virus Infections 10/2018
1	Angiomyolipoma 10/2017
1	Tuberous Sclerosis (Bourneville's Disease) 10/2017
1	Cysts 10/2016
1	Virus Diseases (Viral Diseases) 04/2010
1	Hyperplasia 12/2009
1	Cystic Fibrosis (Mucoviscidosis) 12/2009
1	Bronchiectasis 12/2009
1	Pseudomonas Infections 05/2006
1	Bacterial Infections (Bacterial Infection) 05/2006
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 04/2002

Drug/Important Bio-Agent (IBA)

7	SmokeIBA 07/2020 - 12/2008
6	LigandsIBA 10/2018 - 05/2006
5	CytokinesIBA 01/2020 - 05/2006
5	Acrolein (Aqualin)IBA 12/2009 - 12/2007
4	MucinsIBA 01/2020 - 05/2002
3	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2013 - 05/2006
3	NickelIBA 08/2009 - 12/2005
2	ZincIBA 07/2020 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 11/2009 - 01/2006
2	Surface-Active Agents (Surfactants)IBA 08/2009 - 01/2006
2	AllergensIBA 01/2003 - 04/2002
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	CadmiumIBA 07/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Interleukin-33IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 10/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2017
1	Cytostatic AgentsIBA 10/2017
1	trans-sodium crocetinate (crocetin)IBA 10/2017
1	MTOR InhibitorsIBA 10/2017
1	lipoarabinomannan (LAM)IBA 10/2016
1	C-Type Lectins (C-Type Lectin)IBA 04/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2014
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2014
1	Nucleic AcidsIBA 01/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 06/2010
1	ChemokinesIBA 06/2010
1	PyocyanineIBA 12/2009
1	Pregnenolone Carbonitrile (PCN)IBA 12/2009
1	ExotoxinsIBA 12/2009
1	Virulence Factors (Pathogenicity Factors)IBA 12/2009
1	HemopexinIBA 11/2009
1	Cysteine (L-Cysteine)FDA Link 11/2009
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2009
1	Transforming Growth Factor alpha (TGF-alpha)IBA 08/2009
1	Superoxide DismutaseIBA 05/2009
1	Natural Killer Cell ReceptorsIBA 03/2009
1	AutoantibodiesIBA 12/2008
1	Irritants (Vesicants)IBA 12/2007
1	IgA receptor (protein B)IBA 01/2006
1	MetallothioneinIBA 01/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2005
1	Methacholine Chloride (Methacholine)FDA Link 07/2003
1	3-nitrotyrosineIBA 05/2002
1	PeroxidasesIBA 05/2002
1	ApoproteinsIBA 05/2002
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2014